Health Catalyst Stock Price, News & Analysis

Health Catalyst (HCAT) has acquired ARMUS Corporation, a Silicon Valley firm specializing in clinical registry development and data management. This acquisition aims to enhance Health Catalyst's Clinical Quality and Outsourced Services offerings by integrating ARMUS's technology with its own Data Operating System (DOS™). Health Catalyst expects this strategic move to streamline operations for healthcare organizations and deliver significant financial savings. The collaboration promises to advance data abstraction and registry reporting capabilities, addressing the increasing demand for data-driven insights in healthcare.

Health Catalyst, Inc. (HCAT) reported Q1 2022 financial results, showing a 22% year-over-year revenue increase to $68.1 million, exceeding guidance. Adjusted EBITDA reached $671,000, a significant turnaround from a $(837,000) loss a year prior. Technology revenue rose 25% to $42.2 million, while professional services revenue grew 17% to $25.9 million. The net loss decreased by 21% to $22.5 million, highlighting improved operational efficiency amid labor market challenges. The company aims for continued growth and stability as it marks its third year as a public entity.

Health Catalyst (Nasdaq: HCAT) will release its first quarter 2022 operating results on May 10, 2022, after market close. A conference call to discuss these results is scheduled for the same day at 5 p.m. E.T. Participants can join by dialing (877) 295-1104 for U.S. calls or (470) 495-9486 for international calls, using participant code 2480316. The event will also be streamed live online, with a replay available for approximately 90 days. Health Catalyst specializes in data and analytics technology for healthcare organizations, helping them improve clinical and operational outcomes.

Health Catalyst (Nasdaq: HCAT) announced a strategic partnership with Tallahassee Memorial HealthCare (TMH) on March 10, 2022. This multi-year collaboration aims to implement a scalable analytics platform to consolidate TMH's data sources, supporting clinical improvement in areas like infection rates and patient readmissions. TMH will utilize Health Catalyst’s Data Operating System (DOS™) and Analytic Accelerators for enhanced data access and analytics efficiency. The partnership focuses on improving patient outcomes and operational excellence, marking a significant step toward data-informed healthcare transformation.

Health Catalyst (HCAT) reported strong Q4 and full-year 2021 results, exceeding revenue and Adjusted EBITDA guidance. Q4 revenue reached $64.7M, a 21% increase YoY, while full-year revenue grew 28% to $241.9M. Technology revenue rose 34% to $147.7M, and professional services revenue increased by 20% to $94.2M. Despite a net loss of $48.99M in Q4, the company's dollar-based retention rate improved to 112%. Health Catalyst continues to prioritize consistent performance as a public entity, marking its achievements amid a challenging macro environment.

Health Catalyst (Nasdaq: HCAT) announced its partnership with Temple University Health System on Feb 23, 2022. Temple Health will implement PowerCosting™ from Health Catalyst's Financial Empowerment Suite to enhance financial performance and clinical outcomes. CFO Nick Barcellona emphasized the strategic investment for delivering high-value patient care. This engagement aims to provide insights into true costs and improve resource utilization amidst challenges like shifting payer mixes and rising expenses. Health Catalyst’s CEO Dan Burton expressed confidence in the partnership's potential for measurable healthcare improvements.

Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire KPI Ninja, a provider of interoperability solutions and population health analytics based in Lincoln, Nebraska. The acquisition is expected to enhance Health Catalyst's data processing capabilities and expand its service offerings. KPI Ninja's technology will integrate seamlessly with Health Catalyst's Data Operating System, empowering clients to build customized clinical solutions. The deal aims to strengthen Health Catalyst's position in the healthcare analytics market, with a focus on uninterrupted service delivery to existing KPI Ninja clients.

Health Catalyst, Inc. (Nasdaq: HCAT) will announce its fourth quarter and full year 2021 operational results on March 1, 2022, after market close. A conference call will follow at 5 p.m. E.T. that day, providing insights into the company's performance. Interested parties can access the call by calling (877) 295-1104 for U.S. participants or (470) 495-9486 for international attendees. The event will be available via a live audio webcast, with a replay accessible shortly after the call.

Health Catalyst, a leading provider of data and analytics technology in healthcare, announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. Key executives including CEO Dan Burton, CFO Bryan Hunt, and SVP Adam Brown will present on January 11, 2022, at 3:45 p.m. ET. An audio replay will be available on their investor relations website. With a cloud-based platform powered by over 100 million patient records, Health Catalyst aims to drive data-informed healthcare improvements for its clients.